- Action
- On July 13, 2018, the firm issued an "URGENT-Medical Device Correction" letter dated July 10, 2018, to affected customers to advise them that that monitors with batteries that have exceeded their specified replacement interval may overheat or ignite. The firm issued a Service Guide addendum included with the letter, which contains information to assist with managing the battery and its replacement.
Customers were advised to do the following:
Upon receipt of this notification, carefully read the enclosed SureSigns Addendum to the Service Guide.
VS Series Customers -Addendum to the Service Guide: 453564807541
VM Series Customers -Addendum to the Service Guide: 453564807551
VSV Customers- Addendum to the Service Guide: 453564815301
Promptly perform the Battery Maintenance that is called out in the Addendum for each of your affected Philips SureSigns VS & VM Monitors and View Station (VSV) by determining if the Battery Information Screen indicates if the battery cycle count exceeds the limit of 300 cycles, or the battery is older than three (3) years. If so, the battery needs to be replaced. The replacement battery can be ordered using the standard Philips replacement processes.
Details on how to replace the battery can be found in the Philips SureSigns VS & VM Monitors and View Station (VSV) Service Guide.
Review this information with all staff members who are responsible for device management of the Philips SureSigns VS & VM Monitors and View Station (VSV).
Please store the below Service Guide Addendum with your Philips SureSigns VS & VM Monitors and View Station (VSV) Service Guide documentation.
VS Series Customers -Addendum to the Service Guide: 453564807541
VM Series Customers -Addendum to the Service Guide: 453564807551
VSV Customers- Addendum to the Service Guide: 453564815301
Complete and return the response card provided.
In addition to providing the Service Guide Addendum and this notice, Philips plans to release a customer ins
- Initiated
- 2018-07-13
- Root cause
- Labeling design
- Distribution
- Worldwide distribution: US (nationwide) including Puerto Rico and countries of: Afghanistan, Albania, Andorra, Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Bhutan, Bolivia, Brazil, Bulgaria, Canada, Cambodia, Chile, China, Colombia, Costa Rica, Cote D'Ivoire, Croatia, Czech Republic, Dominican Republic, El Salvador, Egypt, Estonia, Ethiopia, France, French Guiana, French Polynesia, Finland, Guadeloupe, Germany, Ghana, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Israel, Italy, Japan, Jordan, Kenya, Korea, Kosovo, Republic of, Kuwait, Latvia, Lebanon, Lithuania, Luxembourg, Lybia, Macao, Malaysia, Maldives, Malta, Martinique, Mauritius, Mexico, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Norway, Oman, Pakistan, Palestine, State of, Peru, Philippines, Poland, Portugal, Qatar, Reunion, Romania, Russian Federation, Saudi Arabia, Singapore, Slovakia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Tanzania, Thailand, Trinidad and Tobago, Turkey, United Arab Emirates, United Kingdom, Venezuela, Viet Nam, Zambia and Zimbabwe.
- Recall number
- Z-2892-2018
- Recall status
- Open, Classified
- CDRH record ID
- 166078
- FDA record created
- 2018-08-22
- Recall event number
- 80645